Bio Spec Overview
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Last Modification Date:
2025-12-25 @ 3:57 AM
Retention:
SAMPLES_WITH_DNA
Description:
The study population will be composed of participants suspected of a respiratory tract infection from SARS-COV-2, Influenza A/B, or RSV. For this study, 1 nasopharyngeal swab and 1 nasal swab will be collected from each participant recruited prospectively from at least three (3) collection sites located in different geographical regions in the US.
Section:
The study population will be composed of participants suspected of a respiratory tract infection from SARS-COV-2, Influenza A/B, or RSV. For this study, 1 nasopharyngeal swab and 1 nasal swab will be collected from each participant recruited prospectively from at least three (3) collection sites located in different geographical regions in the US.